EULAR 2022  | congress satellite symposia & consult the expert

A number of satellite symposia and consult the expert events will be organised during EULAR 2022, 1-3 June. The full programme will be updated on this page.

Satellite symposia and Consult the Expert are governed by the EULAR Code of Practice, and are strictly prohibited during the official programme hours. All symposia and special events must be approved by EULAR.

SCHEDULE OVERVIEW *
 

WEDNESDAY 1 JUNE

18:30 - 19:45 Satellite symposia (6 parallel sessions)
15:45 - 16:15 Consult the Expert (2 parallel sessions)

THURSDAY 2 JUNE

08:15 - 09:30 Satellite symposia (6 parallel sessions)
09:45 - 10:15 Consult the Expert (3 parallel sessions)
15:00 - 15:30

Consult the Expert (2 parallel sessions)

17:30 - 18:45 Satellite symposia (6 parallel sessions)

FRIDAY 3 JUNE

08:15 - 09:30 Satellite symposia (6 parallel sessions)
09:45 - 10:15 Consult the Expert (3 parallel sessions)
17:30 - 18:45 Satellite symposia (6 parallel sessions)

 

Satellite Symposia Programme overview

01 June | 18:30 - 19:45 CEST 
Boehringer Ingelheim - Challenges in the management of systemic sclerosis-associated interstitial lung disease (SSc-ILD)
Speaker (s): Various 
Session details

01 June | 18:30 - 19:45 CEST 
AbbVie - JAK Inhibitors in Rheumatic Conditions and their Role in Helping Patients Reach Treatment Goals
Speaker (s): Various
Session details

01 June | 18:30 - 19:45 CEST
UCB - Raising the Target for Patients Living with Axial Spondyloarthritis
Speaker (s): Various
Session details

01 June | 18:30 - 19:45 CEST
Pfizer - The Enduring Value of TNF Inhibitors: Lessons Learnt and Opportunities for Further Optimisation
Speaker (s): Various
Session details

01 June | 18:30 - 19:45 CEST
AstraZeneca - Rewriting lupus: turning the page on the management of SLE
Speaker (s): Various
Session details

01 June | 18:30 - 19:45 CEST
Bristol-Myers Squibb - Concept to Practice: Deliberating “At Risk” RA
Speaker (s): Various
Session details

02 June | 08:15 - 09:30 CEST
Pfizer - There is a Cardiologist in the Rheum!
Speaker (s): Various
Session details

02 June | 08:15 - 09:30 CEST
Novartis - Making the invisible visible in PsA and axSpA
Speaker (s): Various
Session details

02 June | 08:15 - 09:30 CEST
Amgen - Slipping through the cracks: Overcoming the challenges in managing patients with moderate PsA
Speaker (s): Various
Session details

02 June | 08:15 - 09:30 CEST
Medac - Methotrexate in current clinical practice: optimizing the anchor drug in RA therapy
Speaker (s): Various
Session details

02 June | 08:15 - 09:30 CEST
Celltrion Healthcare - Rerouting IFX Therapy from IV to SC: Can It Open New Doors?
Speaker (s): Various
Session details

02 June | 08:15 - 09:30 CEST
Fresenius Kabi - Sailing towards the same destination: How do we manage the treatment strategy in RA patients?
Speaker (s): Various
Session details

02 June | 17:30 - 18:45 CEST
AstraZeneca - Elevating Treatment Expectations in SLE
Speaker (s): Various
Session details

02 June | 17:30 - 18:45 CEST
Bristol Myers Squibb - Hidden in Plain Sight: TYK2 as an Emerging Pathway in Lupus and Psoriatic Arthritis
Speaker (s): Various
Session details

02 June | 17:30 - 18:45 CEST
Janssen - Above the stratosphere: a new frontier in PsA management
Speaker (s): Various
Session details

02 June | 17:30 - 18:45 CEST
Galapagos - Evolving patient care: can JAK inhibitors meet patient and physician expectations for RA treatment?
Speaker (s): Various
Session details

02 June | 17:30 - 18:45 CEST
GSK - Looking to the Future of RA Management
Speaker (s): Various
Session details

02 June | 17:30 - 18:45 CEST
Lilly - 5-YEAR’S and BEYOND with Baricitinib
Speaker (s): Various
Session details

03 June | 08:15 - 09:30 CEST
Vifor - An alternative treatment pathway in ANCA-associated vasculitis
Speaker (s): Various
Session details

03 June | 08:15 - 09:30 CEST
AbbVie - Boosting your knowledge of spondyloarthritis: How to navigate the shifting field of axial SpA
Speaker (s): Various
Session details

03 June | 08:15 - 09:30 CEST
UCB - Raising the Target for Patients Living with Psoriatic Arthritis
Speaker (s): Various
Session details

03 June | 08:15 - 09:30 CEST
GlaxoSmithKline - Thinking short- and long-term in SLE: is disease modification possible?
Speaker (s): Various
Session details

03 June | 08:15 - 09:30 CEST
Pfizer - Finding the Balance: Efficacious Treatment of AS While Managing Safety and Risk
Speaker (s): Various
Session details

03 June | 08:15 - 09:30 CEST
Lilly - Spondyloarthritis: treating the patient, not the disease
Speaker (s): Various
Session details

03 June | 17:30 - 18:45 CEST
Janssen - 2022, an ImmunOdyssey: IL-23 pathway in immune-mediated diseases
Speaker (s): Various
Session details

03 June | 17:30 - 18:45 CEST
AbbVie - JAK of All Trades - A new standard of care in RA and PsA?
Speaker (s): Various
Session details

03 June | 17:30 - 18:45 CEST
GlaxoSmithKline - Bridging the gap: building effective patient–clinician communications in systemic lupus erythematosus (SLE)
Speaker (s): Various
Session details

03 June | 17:30 - 18:45 CEST
UCB - Evolving Concepts in axSpA – 2022 Update
Speaker (s): Various
Session details

03 June | 17:30 - 18:45 CEST
CSF - JAK Inhibitors: Translating Data to Clinical Practice
Speaker (s): Various
Session details

03 June | 17:30 - 18:45 CEST
GlaxoSmithKline - Understanding EGPA: A new era for patient management
Speaker (s): Various
Session details




 


 

Consult the expert Programme overview

01 June | 15:45 - 16:15 CEST
GlaxoSmithKline - Thinking short- and long-term in SLE: is disease modification possible?
Speaker(s): Prof. Dr. Ronald van Vollenhoven, Dr. Johanna Mucke, Prof. Luca Iaccarino
Session details

01 June | 15:45 - 16:15 CEST
Galapagos - Patient-centred care in RA: cutting through the jargon
Speaker(s): MD, PhD Lars Erik Kristensen
Session details

02 June | 09:45 - 10:15 CEST
Novartis - AOSD: improving patients’ treatment with targeted strategies
Speaker(s): Prof. Lorenzo Dagna, PD Dr. Jürgen Rech
Session details

02 June | 09:45 - 10:15 CEST
Janssen - Intervene and intercept: can we prevent PsA early in disease development?
Speaker(s): MD, PhD Lars Erik Kristensen, Prof. Lars Iversen
Session details

02 June | 09:45 - 10:15 CEST
Boehringer Ingelheim - Protecting the lungs in patients with autoimmune diseases
Speaker(s): Prof. Dr. Michael Kreuter
Session details

02 June | 15:00 - 15:30 CEST
UCB - Enthesitis Management
Speaker(s): Prof. Rik Lories, Dr. Philippe Carron
Session details

02 June | 15:00 - 15:30 CEST
Pfizer - How to Channel Your Inner Cardiologist!
Speaker(s): Prof. Fabiola Atzeni, MD, PhD Anne Grete Semb
Session details

03 June | 09:45 - 10:15 CEST
Pfizer - An Experience- and Evidence-Based Approach for the Treatment of PsA
Speaker(s): Prof. Laura Coates, Dr. med. Frank Behrens
Session details

03 June | 09:45 - 10:15 CEST
Janssen - Journey to the centre: axial involvement of PsA
Speaker(s): Prof. Dr. Mikkel Østergaard, Prof. Dr. Denis Poddubnyy
Session details

03 June | 09:45 - 10:15 CEST
Vifor - ANCA vasculitis – what should you be concerned about? Assessing the impact of treatment choices
Speaker(s): Prof. Dr. Bernhard Hellmich
Session details

 

* CEST (Central European Summer time)